Aura Biosciences Inc. Insider Trading
AURA
Insiders sold 903K and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Senior Vice President, Finance Amy Elazzouzi sold 43K on Feb 17, 10% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2025.
Get an email when AURA's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Nov 16 | Janet Jill Hopkins Chief Medical Officer | SoldNo plan | 16,903 | $7.05 | 119K | 4.4% | Form 4 |
| Jun 16 | Anthony S Gibney See Remarks | SoldNo plan | 12,824 | $6.42 | 82K | 4.6% | Form 4 |
| May 7 | Matrix Capital Management Company, LP Large holder | SoldNo plan | 6,922,870 | $5.64 | $39M | 100% | Form 4 |
| Apr 16 | Conor Kilroy See Remarks | SoldNo plan | 11,738 | $7.02 | 82K | 5.1% | Form 4 |
| Feb 17 | Conor Kilroy See Remarks | SoldNo plan | 12,079 | $5.05 | 61K | 6.7% | Form 4 |
| Feb 17 | Mark Plavsic Chief Technology Officer | SoldNo plan | 15,890 | $5.05 | 80K | 8.1% | Form 4 |
| Feb 17 | Janet Jill Hopkins Chief Medical Officer | SoldNo plan | 20,401 | $5.06 | 103K | 8.1% | Form 4 |
| Feb 17 | Amy Elazzouzi Senior Vice President, Finance | SoldNo plan | 8,549 | $5.06 | 43K | 10% | Form 4 |
| Feb 17 | Pinos Elisabet De Los See Remarks | SoldNo plan | 47,648 | $5.06 | 241K | 8.1% | Form 4 |
| Jan 20 | Amy Elazzouzi Senior Vice President, Finance | SoldNo plan | 1,581 | $4.86 | 8K | 1.8% | Form 4 |
| Jan 20 | Pinos Elisabet De Los See Remarks | SoldNo plan | 16,928 | $4.86 | 82K | 2.8% | Form 4 |
| Nov 17, 2025 | Janet Jill Hopkins Chief Medical Officer | SoldNo plan | 17,109 | $5.42 | 93K | 6.3% | Form 4 |
| Oct 29, 2025 | Amy Elazzouzi Senior Vice President, Finance | SoldNo plan | 896 | $6.35 | 6K | 1.0% | Form 4 |
| Oct 29, 2025 | Pinos Elisabet De Los See Remarks | SoldNo plan | 9,049 | $6.35 | 57K | 1.5% | Form 4 |
| Oct 16, 2025 | Mark Plavsic Chief Technology Officer | SoldNo plan | 12,169 | $6.35 | 77K | 5.8% | Form 4 |
| Aug 18, 2025 | Amy Elazzouzi Senior Vice President, Finance | SoldNo plan | 7,722 | $6.70 | 52K | 8.2% | Form 4 |
| May 16, 2025 | David Michael Johnson Director | Bought | 20,000 | $4.90 | 98K | 4.6% | Form 4 |
| May 16, 2025 | Anthony S Gibney See Remarks | SoldNo plan | 1,519 | $5.15 | 8K | 2.6% | Form 4 |
| May 16, 2025 | Anthony S Gibney See Remarks | Bought | 50,000 | $4.90 | 245K | 721% | Form 4 |
| Apr 16, 2025 | Amy Elazzouzi Senior Vice President, Finance | SoldNo plan | 897 | $5.49 | 5K | 1.1% | Form 4 |
| Apr 16, 2025 | Conor Kilroy See Remarks | SoldNo plan | 7,162 | $5.49 | 39K | 3.8% | Form 4 |
| Feb 18, 2025 | Mark Plavsic Chief Technology Officer | SoldNo plan | 2,151 | $7.75 | 17K | 1.0% | Form 4 |
| Feb 18, 2025 | Amy Elazzouzi Senior Vice President, Finance | SoldNo plan | 1,404 | $7.75 | 11K | 1.7% | Form 4 |
| Feb 18, 2025 | Janet Jill Hopkins Chief Medical Officer | SoldNo plan | 2,534 | $7.75 | 20K | 0.9% | Form 4 |
| Feb 18, 2025 | Pinos Elisabet De Los See Remarks | SoldNo plan | 20,221 | $7.75 | 157K | 3.2% | Form 4 |
| Jan 21, 2025 | Pinos Elisabet De Los See Remarks | SoldNo plan | 15,955 | $7.67 | 122K | 3.5% | Form 4 |
| Jan 21, 2025 | Amy Elazzouzi Vice President, Finance | SoldNo plan | 1,001 | $7.67 | 8K | 2.5% | Form 4 |
- Nov 16No planJanet Jill HopkinsChief Medical Officer · sold 16,903 at $7.05119K4.4% of stake
- Jun 16No planAnthony S GibneySee Remarks · sold 12,824 at $6.4282K4.6% of stake
- May 7No planMatrix Capital Management Company, LPLarge holder · sold 6,922,870 at $5.64$39M100% of stake
- Apr 16No planConor KilroySee Remarks · sold 11,738 at $7.0282K5.1% of stake
- Feb 17No planConor KilroySee Remarks · sold 12,079 at $5.0561K6.7% of stake
- Feb 17No planMark PlavsicChief Technology Officer · sold 15,890 at $5.0580K8.1% of stake
- Feb 17No planJanet Jill HopkinsChief Medical Officer · sold 20,401 at $5.06103K8.1% of stake
- Feb 17No planAmy ElazzouziSenior Vice President, Finance · sold 8,549 at $5.0643K10% of stake
- Feb 17No planPinos Elisabet De LosSee Remarks · sold 47,648 at $5.06241K8.1% of stake
- Jan 20No planAmy ElazzouziSenior Vice President, Finance · sold 1,581 at $4.868K1.8% of stake
- Jan 20No planPinos Elisabet De LosSee Remarks · sold 16,928 at $4.8682K2.8% of stake
- Nov 17, 2025No planJanet Jill HopkinsChief Medical Officer · sold 17,109 at $5.4293K6.3% of stake
- Oct 29, 2025No planAmy ElazzouziSenior Vice President, Finance · sold 896 at $6.356K1.0% of stake
- Oct 29, 2025No planPinos Elisabet De LosSee Remarks · sold 9,049 at $6.3557K1.5% of stake
- Oct 16, 2025No planMark PlavsicChief Technology Officer · sold 12,169 at $6.3577K5.8% of stake
- Aug 18, 2025No planAmy ElazzouziSenior Vice President, Finance · sold 7,722 at $6.7052K8.2% of stake
- May 16, 2025David Michael JohnsonDirector · bought 20,000 at $4.9098K4.6% of stake
- May 16, 2025No planAnthony S GibneySee Remarks · sold 1,519 at $5.158K2.6% of stake
- May 16, 2025Anthony S GibneySee Remarks · bought 50,000 at $4.90245K721% of stake
- Apr 16, 2025No planAmy ElazzouziSenior Vice President, Finance · sold 897 at $5.495K1.1% of stake
- Apr 16, 2025No planConor KilroySee Remarks · sold 7,162 at $5.4939K3.8% of stake
- Feb 18, 2025No planMark PlavsicChief Technology Officer · sold 2,151 at $7.7517K1.0% of stake
- Feb 18, 2025No planAmy ElazzouziSenior Vice President, Finance · sold 1,404 at $7.7511K1.7% of stake
- Feb 18, 2025No planJanet Jill HopkinsChief Medical Officer · sold 2,534 at $7.7520K0.9% of stake
- Feb 18, 2025No planPinos Elisabet De LosSee Remarks · sold 20,221 at $7.75157K3.2% of stake
- Jan 21, 2025No planPinos Elisabet De LosSee Remarks · sold 15,955 at $7.67122K3.5% of stake
- Jan 21, 2025No planAmy ElazzouziVice President, Finance · sold 1,001 at $7.678K2.5% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Biological Products, (No Diagnostic Substances) · Pick stocks to compare with AURA
Held by ETFs
AURA is in 13 US ETFs. The largest of them, with AURA's weight in each:
Spot a number that looks wrong? Check it in AURA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing AURA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.